A Comparitive Evaluation of Blood Sugar and Glycosylated Haemoglobin in Clinically Manifested Diabetic Neuropathy


  • Ponnala Suresh Senior Resident, Department of General Medicine, Govt Medical College/Hospital, Suryaet, Telangana, India


HbA1c, Blood Sugar, Neuropathy, Diabetes.


Aim & Objective: The present study has been undertaken to monitor the levels of blood sugar and HbA1C in diabetic neuropathyMethodology: The present study was conducted at Mahatma Gandhi Memorial Hospital, Warangal. The study was undertaken between June’2018 to May’2019 both in inpatient and outpatient department. Diabetic patients seeking consultation for the symptoms suggestive of neuropathy were screened and labeled as suffering from diabetic neuropathy based on the inclusion and exclusion criteriaResults: 60 patients of diabetic neuropathy were studied Out of them36 were males and 24 were female.The age of the patients varied between to 16 years to 70 years (mean:52.2yrs).The incidence of IDDM were 2 and that of NIDDM were 58.The duration of diabetes varied from0 to 25 years (mean 8.7 years).Only 11 patients received regular treatment. Symptoms of sensory system involvement were the most common 47 (78.3%) patients followed by motor symptoms 20 (33%) cases. Autonomic symptoms 10 cases and cranial nerve symptoms 2 cases. Examination of the cranial nerve revealed diabetic retinopathy in 33 patient,I IIrd cranial nerve palsy in 2 patient and LMN facial nerve palsy in one patient. Symmetrical sensory loss was confined to the lower limbs in all patients. Distal symmetric sensory neuropathy was the most common type of clinical neuropathy. III cranial nerve palsy was the most common cranial neuropathy. Motor and autonomic neuropathies were found in significant number of patients. Blood sugar estimation revealed evidence of poor control in 12 patients (20%). In patients with peripheral neuropathy with or without associated complications of diabetes (Like retinopathy, autonomic neuropathy) estimation of glycosylated hemoglobin was a better indicator of poor metabolic control.Conclusion: The efficacy of glycosylated hemoglobin estimation in assessing diabetic control is not influenced by Age, Sex, duration, or diabetes and a mode of therapy.Longer the duration and poorer the control of diabetes, more are the chance of development of the complications of diabetes.



2022-02-15 — Updated on 2022-01-18


How to Cite

Ponnala Suresh. (2022). A Comparitive Evaluation of Blood Sugar and Glycosylated Haemoglobin in Clinically Manifested Diabetic Neuropathy. International Journal of Health and Clinical Research, 5(3), 236–242. Retrieved from https://ijhcr.com/index.php/ijhcr/article/view/4354 (Original work published February 15, 2022)